| |
| |
|
| Insider
Information: |
Derbyshire Adam C |
| Relationship: |
EVP Finance/CFO |
| City: |
Raleigh |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
218,463 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
218,463 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Salix Pharmaceuticals Ltd |
SLXP |
EVP Finance/CFO |
2014-08-22 |
218,463 |
2006-07-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
189 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 7 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2009-10-28 |
4 |
AS |
$19.79 |
$98,950 |
D/D |
(5,000) |
108,371 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2009-11-04 |
4 |
OE |
$1.13 |
$5,667 |
D/D |
5,000 |
113,371 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2009-11-04 |
4 |
AS |
$19.60 |
$98,489 |
D/D |
(5,000) |
108,371 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2009-11-11 |
4 |
AS |
$20.12 |
$100,600 |
D/D |
(5,000) |
108,371 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2009-11-11 |
4 |
OE |
$1.13 |
$5,667 |
D/D |
5,000 |
113,371 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2009-11-18 |
4 |
OE |
$1.13 |
$5,667 |
D/D |
5,000 |
113,371 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2009-11-18 |
4 |
AS |
$21.05 |
$105,250 |
D/D |
(5,000) |
108,371 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2009-11-25 |
4 |
OE |
$1.13 |
$5,667 |
D/D |
5,000 |
113,371 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2009-11-25 |
4 |
AS |
$23.58 |
$117,900 |
D/D |
(5,000) |
108,371 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2009-12-02 |
4 |
AS |
$23.37 |
$116,850 |
D/D |
(5,000) |
108,371 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2009-12-02 |
4 |
OE |
$1.13 |
$5,667 |
D/D |
5,000 |
113,371 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2009-12-09 |
4 |
OE |
$1.13 |
$5,667 |
D/D |
5,000 |
113,371 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2009-12-09 |
4 |
AS |
$23.10 |
$115,500 |
D/D |
(5,000) |
108,371 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2010-07-01 |
4 |
D |
$39.03 |
$336,204 |
D/D |
(8,614) |
99,757 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2010-07-19 |
4 |
A |
$0.00 |
$0 |
D/D |
19,520 |
119,277 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2011-04-25 |
4 |
A |
$0.00 |
$0 |
D/D |
25,955 |
145,232 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2011-07-01 |
4 |
D |
$39.83 |
$447,769 |
D/D |
(11,242) |
133,990 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2012-01-03 |
4 |
D |
$47.85 |
$136,468 |
D/D |
(2,852) |
131,138 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2012-01-17 |
4 |
OE |
$4.07 |
$13,656 |
D/D |
3,358 |
134,496 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2012-01-17 |
4 |
AS |
$50.06 |
$168,098 |
D/D |
(3,358) |
131,138 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2012-01-18 |
4 |
OE |
$4.07 |
$1,525 |
D/D |
375 |
131,513 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2012-01-18 |
4 |
AS |
$4.07 |
$1,525 |
D/D |
(375) |
131,138 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2012-02-13 |
4 |
AS |
$50.00 |
$644,550 |
D/D |
(12,891) |
131,138 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2012-02-13 |
4 |
OE |
$4.07 |
$52,423 |
D/D |
12,891 |
144,029 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2012-02-28 |
4 |
OE |
$4.07 |
$51,239 |
D/D |
12,600 |
143,738 |
0 |
- |
|
189 Records found
|
|
Page 7 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
